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Edited by Irmgard SinningAbstract The X-ray crystal structures of ﬁve distinct enzymes
(prostaglandin H2 synthase, squalene cyclase, fatty acid amide
hydrolase, microsomal cytochrome P450, and estrone sulfatase)
challenge contemporary descriptions of integral membrane
proteins. This structurally divergent group represents an impor-
tant component of the integral membrane proteome that lies at
the bilayer’s aqueous interface. We summarize here what is
collectively understood about the membrane insertion of these
proteins, what roles they may play in lipid biology, and their
relationship to soluble structural homologs.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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As our collective understanding of protein structure and
function becomes more advanced, we are able to identify
commonalities among groups of polypeptides and use these
trends as a means to categorize them. At the simplest level, the
cellular proteome is divided according to solution behavior
and comprises both soluble and membrane fractions. Members
of the membrane population may be peripherally associated
with the membrane surface by means of ionic forces, cova-
lently attached by post-translational lipid modiﬁcation, or
stably reside in the bilayer itself by virtue of hydrophobic in-
teractions [1,2].
Those proteins that fall in the ﬁrst two categories of the
membrane population can be stripped oﬀ the membrane with
washes of high ionic strength or alkaline buﬀers while leaving
the membrane itself intact. These proteins are classiﬁed as
peripheral membrane proteins. Their proteinaceous contacts
with the bilayer do not require interactions deeper than the
head group and intermediate phases of the membrane [3], and
these interactions may be reversibly regulated, as is the case for
some phospholipases [4]. The third group, the integral mem-
brane proteins (IMPs), displays large hydrophobic surfaces
that interact with the acyl core of the lipid bilayer. These
proteins cannot be separated from the membrane without* Corresponding author. Fax: +1-858-784-9483.
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doi:10.1016/j.febslet.2004.04.084disruption of the bilayer itself and require detergents for
solubilization.
At a more detailed level, the IMPs exhibit three basic modes
of bilayer insertion, or topology. This distinction is made at
the level of the membrane itself and how many times the
polypeptide chain traverses it. The concept of monotopic
membrane proteins was hinted at in the original works of
Singer and Nicolson [5] and was explicitly put forward by
Blobel [6], where he delineated proteins that cross the mem-
brane once as bitopic, twice or more as polytopic, and not at
all as monotopic. He went on to espouse the now widely rec-
ognized means by which topogenic sequences within the pro-
tein’s primary structure may dictate these various insertion
strategies.
Since the ﬁrst detailed structural characterization of an in-
tegral membrane protein [7], we have further reﬁned our
classiﬁcation schemes. Based on a survey of available X-ray
and nuclear magnetic resonance (NMR) structures, structural
biologists have divided the IMPs into an a class and a b class
according to the polypeptide conformations of their lipid
embedded domains [3,8,9] (Fig. 1). As these designations re-
ﬂect membrane binding motifs and not protein folds per se, the
aIMP and bIMP classes do not necessarily reﬂect the ‘‘all a’’ or
‘‘all b’’ folds described for soluble proteins (http://
scop.berkeley.edu). Collectively, solubility, topology, and
membrane binding motifs provide a hierarchy of independent
parameters that may be combined to describe any single
membrane protein.
Members of the aIMP class can internally satisfy all hy-
drogen bonding requirements within a single transmembrane
segment [3]. This property gives rise to several known means of
bitopic membrane insertion, which are deﬁned by the polarity
and location of the transmembrane domain within the pro-
tein’s primary structure [6,10]. Alternately, aIMPs can traverse
the bilayer two or more times to produce polytopic insertions
of helix bundles [3,11]. When fully assembled in their native
membranes, aIMPs may exist as monomers or oligomers, and
examples have been described in which quaternary protein–
protein interactions occur within the transmembrane helices
themselves [3,12,13]. Outside the bilayer, the hydrophilic do-
mains of these proteins may exhibit enzymatic activity, serve as
anchors for soluble proteins, dictate organelle residency,
transfer reductive equivalents in electron transport, or dock
ligands for signal transduction. These extramembrane domains
may arise from the concerted folding of several loops from aation of European Biochemical Societies.
Fig. 1. Ribbon diagrams of representative proteins of the classes dis-
cussed here: a integral membrane protein (bacteriorhodopsin, 1QHJ;
green); b integral membrane protein (outer membrane cobalamin
transporter Btub, 1NQE; brown); and PGHS (1PRH; gold). The
boundary of a cell membrane is approximated by gray lines.
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[11]. In the case of the latter, bitopic membrane proteins, the
transmembrane domain constitutes an anchor that can be
proteolytically cleaved to free the soluble, globular extra-
membrane domain. As a correlate to their diversity, the aIMPs
collectively possess a rich heterogeneity of function, and ex-
amples of solved structures include photosystems (PDB entry
2PPS), receptors (1F88), respiratory proteins (1L0V), channels
(1BL8), and pumps (1EUL).
In contrast, members of the bIMPs form membrane pores
allowing the passage of various metabolites and small mole-
cules [9], and at least two representatives of this class also
possess enzymatic activity [14,15]. These proteins have only
been observed in the outer membranes of Gram negative
bacteria, mitochondria, and chloroplasts. The bIMPs form
barrels of diﬀering sizes and shapes, may exist as monomers or
oligomers, and traverse the bilayer anywhere from 8 to 22
times [9]. They are strictly polytopic in nature. Several X-ray
and NMR structures have been solved for this class and ex-
amples include outer membrane phospholipase A (1QD5),
maltoporin (1MAL), OmpA (1G90), and TolC (1EK9).Fig. 2. The ﬁve known integral membrane proteins that do not conform to th
cyclase, SQC; fatty acid amide hydrolase, FAAH; cytochrome P450, P450; es
themselves within the lipid core of the cell membrane are colored in green.Despite intense biological and pharmaceutical interest, the
IMPs remain a relatively small population in the Protein Data
Base compared to soluble proteins (http://www.rcsb.org/pdb/).
As a result, our insights into structural motifs that engage the
bilayer continue to rely heavily on inference from members of
the a and b classes, homology modeling, and hydropathy al-
gorithms. It follows, then, that our overall view of protein fold
space in the context of the lipid bilayer is a narrow one. Either
protein fold evolution has found only a few means to stably
insert a polypeptide into a cellular membrane, or there exist
new IMP motifs to discover. This latter possibility advocates
the need for continued structural analysis of membrane pro-
teins, which has the potential to reveal new, unanticipated
means by which polypeptides might stably reside within cell
bilayers. Indeed, such a structural revelation has occurred
during the past decade and challenges us to expand our current
view of membrane protein structure.2. A new structural class of integral membrane proteins
Presently, the X-ray crystal structures of ﬁve distinct integral
membrane proteins have been described that cannot strictly be
placed into either the aIMP or bIMP classes (Fig. 2). They are
prostaglandin H2 synthase [16], squalene cyclase [17], fatty
acid amide hydrolase [18], microsomal cytochrome P450 [19],
and estrone sulfatase [20]. Despite the absence of fold or se-
quence homology among these proteins, many structural and
biochemical features are held in common among them. First,
they are all enzymes that are able to function on lipophilic
substrates and with soluble homologs. Second, each protein
engages the hydrophobic core of the bilayer with motifs that
run parallel to the membrane surface. These motifs form
apolar plateaus that are hypothesized to bury into one leaﬂet
of the membrane only. Third, these enzymes do not adhere to
the accepted notion that IMPs strictly utilize either a or b el-
ements; they collectively exhibit a combination of a helices, b
sheets, loops, and turns in their membrane binding motifs.e aIMP or bIMP classes. Prostaglandin H2 synthase, PGHS; squalene
trone sulfatase, ES. The hydrophobic domains that are believed to bury
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The prostaglandin H2 synthases (PGHS, COX) are the
pharmacological targets of analgesic non-steroidal anti-in-
ﬂammatories (NSAIDs) [21–23]. These dual function enzymes
convert arachidonic acid ﬁrst to prostaglandin G2 by a cy-
clooxidase step and then to prostaglandin H2 via a separate
peroxidase activity. PGHS is known to behave as an integral
membrane protein of the endoplasmic reticulum based on the
inability to extract the enzyme from microsomes using per-
chlorate to strip away peripheral membrane proteins [24,25].
They are oriented to the luminal side of the membrane where
they are glycosylated and form intramolecular disulﬁde bonds
[16,21]. The PGHS proteins can be divided into three domains:
an epidermal growth factor-like domain, a hydrophobic do-
main, and a domain resembling soluble mammalian peroxi-
dases such as myeloperoxidase [16]. Accordingly, it has been
suggested that PGHS evolved by the modular adaptation of a
soluble precursor [26].
The X-ray crystal structure of PGHS-I puriﬁed from sheep
seminal vesicles reveals a dimer with a helical content, simple
twofold symmetry, and an overall ellipsoidal structure [16]
(Fig. 2). The dimer is aligned such that the active site entrances
of each constituent monomer fall on the same face of the ho-
loenzyme in a ‘‘parallel’’ quaternary assembly. Conspicuously
absent from the structure are any excursions from the body of
the protein that might make up a transmembrane domain to
explain the integral membrane behavior of the enzyme. How-
ever, surface hydrophobicity analysis reveals a concentration of
apolar amino acids on one face of the dimer surrounding the
active site entrances [16]. This hydrophobic ‘‘plateau’’, is
formed by four amphipathic helices and their joining turns,
denoted A through D, from each monomer [16]. The concerted
presentation of all eight helices on one face of the protein re-
sults from the dimer symmetry axis and is colocalized with the
entrances to each monomer’s active site [26]. This membrane
protein structure, therefore, not only represents the ﬁrst devi-
ation from the a and b classes but also demonstrates monotopic
topology.
As the prototype of a potentially new class of integral
membrane proteins, the PGHS-I structure illustrates several
salient features (Table 1). Most striking, the simple rendering
of the backbone trace as a ribbon drawing does not confer anyTable 1
Unifying characteristics of integral membrane proteins that fall outside the
Protein PDB
code
Soluble
homolog
Integral
membrane
Hydrophobic
plateau
PGHS (sheep) 1PRH U U U
SQC (Alicyclobacillus) 1SQC U U U
FAAH (rat) 1MT5 U U U
ES (human) 1P49 U U U
P450 (human) 1OG2 U U U
MDH (Pseudomonas) 1HUVa U U U
SppA (Arabidopsis)  U
MgPIXMT (Arabidopsis)  U
Stomatin (human)  U
MAO (human) 1GOS U U 
Fields for which no entry appears are undetermined. Properties of those p
sequence analysis. Topology is indicated as monotopic (M), bitopic (B), or po
or bitopic.
a This structure was solved from a soluble chimera; the existence of the hydr
inferred from the soluble structure.
b The exact function of stomatin is unknown.indication that this protein resides within the hydrophobic
conﬁnes of a cellular membrane. Instead, the three-domain
fold conceptually resembles the gross, overall shape of a
globular soluble protein, something that is not easily said of
the a or b membrane proteins. Additional features that have
proven common to several subsequent IMP structures include
structural homology with a soluble protein, the parallel qua-
ternary orientation of individual subunits of the homooligo-
mer, a hydrophobic prominence on one face of this oligomer,
and the coincident presentation of this membrane-inserting
domain with the active site entrance. Further, the functional
signiﬁcance of these structural elements of PGHS-I is sup-
ported by their total conservation in PGHS-II [22].
2.2. Squalene-hopene cyclase
The determination of the X-ray crystal structure of squa-
lene-hopene cyclase (SQC) from Alicyclobacillus acidocalda-
rius demonstrated that the unusual structural properties of
PGHS are not restricted to higher eukaryotes [17]. Given the
absence of sequence, structural, or enzymatic homology be-
tween SQC and PGHS, this observation suggests that the
evolution of novel membrane insertion motifs was a conver-
gent event. SQC represents a family catalyzing the cyclization
of linear terpenoids to fused ring structures; in mammals, this
process provides precursors for cholesterols and steroid hor-
mones [27]. The enzyme cosediments with membrane fractions
and cannot be liberated by variations in pH from 6 to 9,
stripping with 1 M KCl, dialysis against distilled water, or
washing with 0.1 M EDTA [28]. Furthermore, the yeast en-
zyme can be quantitatively extracted from membranes only
with detergents [29].
The fold of SQC forms two domains, and one of these re-
sembles soluble glucanases and a farnesyltransferase [17]. Like
PGHS, SQC is a dimer with a concerted presentation of two
hydrophobic plateaus on one face of the holoenzyme with a
combined surface area of 1600 A2 (Fig. 2). And again like
PGHS, these presumed membrane-binding domains are coin-
cident with the entrances to the active sites of the SQC dimer.
In contrast to PGHS, however, the hydrophobic plateau pre-
sented by SQC does not comprise a contiguous protein stretch,
but rather three separate domains of primary structure [17,27].
This patch is also partly composed of regions lacking periodicaIMP and bIMP classes
Lipid embedded
AS entrance
Parallel
multimer
Topology Enzyme Hydrophobic
substrates
U U M U U
U U M U U
U U M/B? U U
U monomer P U U
U monomer M/B? U U
U U M U U
M U peptide bond
M U U
M b
 U B U 
roteins without solved structures are based on biochemical data and
lytopic (P). It is presently unknown if FAAH and P450 are monotopic
ophobic plateau and its coincidence with the entry to the active site is
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and between helices a 15 and a 16. Hence, in SQC we see again
non-repetitive elements of protein structure that presumably
interact with the hydrophobic core of the lipid bilayer. Since
the protein shows no potential for traversing the thickness of
the membrane, SQC, like PGHS, can also be described as
monotopic.
2.3. Fatty acid amide hydrolase
The X-ray crystal structure of a recombinant, N-terminal
truncated form of rat fatty acid amide hydrolase (FAAH)
recapitulates many of the features seen in PGHS and SQC
despite an absence of homology [18]. The overall shape of
the protein is globular, with no apparent motifs to function
as a transmembrane domain. The enzyme crystallized as a
dimer such that the active site entrances of each monomer
are oriented in the same direction, and this face of the dimer
is again highly hydrophobic and a likely means by which the
enzyme inserts into the bilayer (Fig. 2). Like the previous
two membrane proteins, FAAH also acts upon lipid sub-
strates and probably gains access to these bilayer-embedded
molecules by the intimate relationship shared between its
membrane-binding domain and active site. Notably, FAAH
also possesses a second, lateral access channel leading from
the cytoplasm to the active site that may facilitate the si-
multaneous transport of water and hydrophilic reaction
products.
Much like PGHS and SQC, FAAH also retains a protein
fold that essentially mimics soluble relatives [18]. In the same
year that the FAAH structure was determined, independent
groups solved the structures of two soluble homologs [30,31].
This coincidence allowed the direct comparison of three vari-
ants of the same protein fold. One soluble relative, malo-
namidase MAE2, completely lacks the amino acid stretch that
composes FAAH’s membrane-binding domain [31]. In this
sense, the insertion of this structural element suggests a mod-
ular adaptation of a basic fold to direct the new protein to the
cell membrane and recapitulates observations made for PGHS.
Further, when FAAH’s structure is compared to the peptide
amidase PAM, one sees that these two enzymes share the
presence of this domain, but the one present in PAM is made
up of hydrophilic residues [30]. Thus, PAM may conceptually
represent a structural transition leading to the integral mem-
brane association seen in FAAH. The case for these argu-
ments, at least from a protein engineering point of view, could
be made in the future by constructing soluble variants of
FAAH based upon these observations.
In comparison to soluble homologs, it is interesting to note
that FAAH bears an amino terminal extension of roughly 35
amino acids that is predicted by primary sequence analysis to
form a transmembrane helix [32]. However, the crystallized
FAAH truncation lacking this domain still behaves as an
IMP, presumably due to the presence of its hydrophobic
plateau domain. Both wild-type and truncated forms of the
enzyme remain bound to microsomes after stripping with
alkaline carbonate [33]. A conclusive demonstration of the
role served by the amino terminus, and therefore the protein’s
true topology, remains lacking. As a result, clarity on this
issue will likely require the solution of the full-length protein
structure or a demonstration that the amino and carboxyl
termini of the protein are mutually inaccessible in native
membranes.2.4. Microsomal cytochrome P450
Structures of mammalian P450s have been solved recently
from both rabbit [19] and man [34]. In contrast to the soluble
P450s from bacteria, these IMPs are localized to the endo-
plasmic reticulum and, like other microsomal P450s, bear a
hydrophobic amino terminus thought to mediate membrane
binding as a transmembrane helix [35]. However, collections of
truncation and mutation studies among various P450 isozymes
show that this domain is not required for irreversible mem-
brane insertion; both wild-type and truncated forms of the
P450 isozymes 2E1 and 2B4 remain bound to microsomes
following alkaline carbonate washes [36,37]. Additionally,
NMR spectra of the would-be transmembrane helix support a
model in which this domain does not traverse the bilayer but
instead resides within only one leaﬂet [38]. In fact, the ho-
mologous mitochondrial P450s, though membrane proteins
also, do not even bear this amino terminal domain [39]. Ex-
periments relying on epitope accessibility assays demonstrate
that domains believed to be associated with the entrance to the
active site are occluded by the membrane itself [40], and NMR
data implicate additional regions in penetration of the mem-
brane as well [41].
The X-ray crystal structures of soluble mutant P450s
CYP2C5 and CYP2C9 provide a structural basis for explain-
ing this rich collection of biochemical data [19,34]. As de-
scribed, this enzyme is globular with a hydrophobic face
(Fig. 2). Like PGHS, SQC, and FAAH, this face also provides
access to the active site, and the authors speculate that ‘‘the
substrate access channel. . .is buried in the lipid core’’ [19]. This
arrangement likely facilitates the recruitment of this enzyme’s
hydrophobic substrates, a property that seems common to the
unconventional IMPs described here. These structural ele-
ments correspond to the F/G loop, B’ helix, and the ﬁrst two
strands of beta sheet 1, and these domains all correspond to
the same sequences implicated by biochemical data as mem-
brane embedded [34]. Additionally, like FAAH, this protein
also shows a second, cytoplasmic approach to the active site
that is likely the means by which reductive equivalents are
transferred from cytochrome P450 reductase. These observa-
tions support the conclusion that members of the microsomal,
and presumably the mitochondrial, P450s bind their respective
membranes with structural motifs ﬁrst observed in PGHS.
2.5. Estrone sulfatase
Human estrone sulfatase (steroid sulfatase, ES) removes
sulfate groups from sterols such as dehydroepiandrosteron
sulfate and cholesterol sulfate to ultimately produce choles-
terol, androgens, and estrogens [42]. The protein cannot be
extracted from microsomes following washes with 0.5 M KCl
or 0.1 M Na2CO3, and it partitions with the detergent during
Triton X-114 phase separation [42]. Therefore, ES is classiﬁed
as an integral membrane protein.
The structure of this enzyme was recently solved and is es-
sentially superimposable with the soluble aryl sulfatases A and
B [20]. Additionally, ES displays many of the hallmarks de-
scribed for the above four IMPs: it is an enzyme that acts on
hydrophobic, albeit sulfated, substrates; the entrance to the
active site is proposed to be associated with the bilayer; and two
hydrophobic strand regions of 20 and 32 amino acids each are
positioned at the active site opening to penetrate the lipid core
[20] (Fig. 2). It thus seems reasonable to assume that ES also
gains access to its hydrophobic susbstrates by direct recruit-
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that the enzyme’s active site itself is buried in the cell membrane
[43].
The structure also conﬁrms prior biochemical evidence that
this enzyme is anchored in the membrane by an additional
structural motif, a transmembrane hairpin formed by helices 8
and 9 [42]. These helices, as well as the two strand segments
mentioned above, are absent in soluble homologs of this
protein, and it remains unclear if either of these domains is
necessary or suﬃcient for membrane binding. Since this en-
zyme is monomeric, it is possible that the presence of one set of
the hydrophobic strands is not suﬃcient to maintain mem-
brane integration. Accordingly, it would be interesting to learn
if deletion of this hairpin abolished membrane binding. It has
been reported that the non-translocated in vitro translation
product of a deletion mutant that lacks the transmembrane
hairpin and/or one of the hydrophobic strands ‘‘strongly ad-
hered to microsomes’’ [42]. However, the translation product
was not shown to be folded or enzymatically active. Overall,
ES possesses the attributes of a polytopic transmembrane
protein combined with the membrane association strategies of
PGHS.3. Other speculatively similar IMPs currently under
investigation
3.1. Monoamine oxidase B
The X-ray crystal structure of the integral membrane protein
monoamine oxidase B (MAO) satisﬁes some of the trends
observed in the above proteins including a parallel dimer ar-
rangement, a dimerization axis perpendicular to the plane of
the membrane, and the existence of soluble homologs [44].
However, many other properties of this enzyme counter its
comparison to the above described enzymes (Table 1). For
instance, MAO’s biological substrates, including dopamine
and epinephrine, are not particularly hydrophobic and parti-
tion quite easily into the aqueous phase. It therefore seems
unlikely that the MAO active site entrance would be buried in
the hydrophobic lipid core. In fact, in comparison with the
related polyamine oxidase, observations suggest that the pro-
tein interacts with the anionic surface of the mitochondrion
membrane and not the acyl portion [45].
It is generally accepted that MAO B associates with mem-
branes through a carboxy-terminal transmembrane helix that
is absent in the soluble homologs polyamine oxidase [46] and
L-amino acid oxidase [47]. MAO mutants lacking this domain
display up to 48% release into the soluble fraction [48]. Fur-
ther, since this partitioning was not measured after harsh
washes of the membranes (e.g., chaotropes, high salt, and al-
kaline carbonate), it remains possible that the truncations with
residual bilayer associations behave merely as peripheral
membrane proteins. If one were to make predictions for MAO
based on the ﬁve proteins described above, the two turn re-
gions situated about residues 110 and 157 should each exhibit
extensive hydrophobicity and bury themselves in the cellular
bilayer. However, these domains do not seem suited to this
function. Though the authors note that Pro109 and Ile110 are
positioned so that they could interact with the membrane [44],
the equivalent surface in the soluble homolog L-amino acid
oxidase displays similar properties with numerous proline,
valine, alanine, leucine, and isoleucine residues [47]. Withoutfurther functional characterization of these structural elements
in MAO, it currently seems unwarranted to regard this enzyme
in the same class as PGHS, SQC, FAAH, P450, and ES. Ra-
ther, MAO more readily favors inclusion as a bitopic member
of the a class.
3.2. Mandelate dehydrogenase
A search of the current literature yields clues to the identities
of other potential IMPs with structural features initially de-
scribed for PGHS even where structure is not currently
available (Table 1). The enzyme mandelate dehydrogenase
(MDH) is an integral membrane protein with soluble homo-
logs. Though an X-ray structure is unavailable for MDH,
structures are available for its soluble relative, glycolate oxi-
dase (GOX), from spinach [49]. Using sequence comparison
and homology modeling, soluble MDH chimeras were engi-
neered by replacing a hydrophobic stretch unique to MDH
with the corresponding domain of GOX [50]. And the X-ray
crystal structure of one of these chimeras reveals a tetrameric
enzyme with many of the features outlined for the unusual
IMPs here, including a predicted hydrophobic face coincident
with the active site entrances in a parallel tetramer [51]. MDH,
then, may represent the ﬁrst member of this group to be en-
gineered into a soluble form.
3.3. Monotopics
Since monotopic topology seems inaccessible to members of
the accepted aIMP and bIMP classes, this feature might be
exploited as a means to identify potential new proteins that
adopt the membrane binding characteristics of PGHS. In
plants, investigators have proposed that both the chloroplast
protease SppA [52] and methyltransferase MgPIXMT [53] are
monotopics based on their primary structure, subcellular lo-
calizations, protease sensitivities, and resistance to ionic or
chaotropic stripping. Curiously, the methyltransferase can be
stripped by 0.1 N NaOH but not by 0.1 M Na2CO3 at pH 11,
and the authors oﬀer this as evidence that the protein is not
transmembrane [53]. In mammals, sequence analysis provides
evidence that stomatin, or erythrocyte band 7.2b, contains a
single transmembrane helix. However, this protein is phos-
phorylated on both the amino and carboxy termini, suggesting
that it either has an additional transmembrane helix or is also
monotopic [54]. Overall, these divergent proteins suggest that
the novel mode of membrane insertion adopted by PGHS and
the above described proteins may be a common, perhaps even
preferred means of addressing enzymatic needs within mem-
branes since it structurally allows protein active sites to engage
the lipid core without the constraints of pure a or pure b folds.
This approach further provides the cell an adaptive means of
recruiting virtually any enzymatic chemistry from the soluble
proteome for use in lipid metabolism without the challenge of
de novo protein design.4. Conclusions
Many of the IMPs described here are the targets of drugs
and drug development programs, and the solution of their
structures in many instances is probably the result of their
medical relevance. For example, PGHS has long been targeted
by aspirin and countless other NSAIDs [21–23,55]. Likewise,
the Candida homolog of SQC has been suggested as a target
164 M.H. Bracey et al. / FEBS Letters 567 (2004) 159–165for anti-fungals using substrate-mimicking inhibitors [56].
FAAH inhibition is currently under pursuit as a means to
intersect the endogenous cannabinoid system for the treatment
of pain and other neurological disorders [57,58]. Estrone sul-
fatase activity is correlated with the proliferation of breast
carcinomas, and the heritable X-linked mutation of this gene
results in ichthyosis [20]. The P450 prostacyclin synthase
produces the platelet anticoagulator and strong vasodilator
prostaglandin I2 [59], while other isozymes are responsible for
various modes of detoxiﬁcation and drug metabolism [60].
Together, these enzymes and their substrates point to the
powerful roles that lipids play in physiology and hint at an
emerging division of integral membrane proteins so rich in
potential drug targets that it could represent the enzymological
equivalent of the G-protein coupled receptors [61].
Clearly, we still have much to learn about structure–function
relationships at the protein–lipid interface. We have described
here a newly emerged understanding of a third means by which
polypeptides may stably reside within cellular bilayers without
the constraints of the aIMP and bIMP paradigms. These ﬁve
IMPs, PGHS, SQC, FAAH, P450, and ES may comprise a
new grouping of lipid-active enzymes that have seemingly
evolved from soluble precursors. In at least two instances, they
defy the once accepted convention that IMPs must traverse
both leaﬂets of the bilayer. They collectively also display a
combinatorial appropriation of peptide backbone geometries
within their membrane-embedded domains, and this appears
in stark contrast with the all a and all b means by which other
membrane proteins engage the hydrophobic core. With the
accumulation of more structures and a heightened awareness
of the importance of these integral membrane enzymes, this
group is sure to provide yet another fascinating ﬁeld for in-
vestigation by structural biologists and may eventually war-
rant a class of its own.
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